Author Archive for Food and Drug Adminstration (FDA): CDRHNew



The committee will discuss, make recommendations, and vote on a premarket approval application for a laboratory assay designed for the rapid detection of clinically relevant (greater than 0.2 millimeters) metastases in lymph node tissue removed from…

The FDA is announceing a forthcoming meeting of the Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee which will be open to the public.

This document provides guidance to manufacturers and assemblers of x-ray computed tomography (CT) equipment and to FDA staff.

Topics: Breast Implants, Breast Prostheses, Key Websites, Silicone

The Food and Drug Administration Modernization Act (FDAMA) requires that manufacturers track certain devices when the agency orders them to do so. Tracking is intended to facilitate notification and recall in the event a device presents a serious risk…

This guidance document identifies the device description, preclinical, clinical, and labeling information we recommend you present in a premarket approval application (PMA) for a breast implant. This guidance document may also be useful in preparing an…

PDF format only. Topics: Breast Implants

PDF format only. Topics: Breast Implants

Under Title 21 of the Code of Federal Regulations §1002.50 (21 CFR 1002.50), FDA may exempt manufacturers of electronic products from reporting and recordkeeping requirements subject to any conditions necessary to protect the public health…

Under Title 21 of the Code of Federal Regulations §1002.50 (21 CFR 1002.50), FDA may exempt manufacturers of electronic products from reporting and recordkeeping requirements subject to any conditions necessary to protect the public health…

The FDA isannouncing an opportunity for public comment on the proposed collection of certain information by the agency on requirements relating to shipment of nonsterile devices to be sterilized elsewhere or are shipped to other establishments for further

The FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

The committee will discuss, make recommendations, and vote on a premarket approval application for a collagen material, which contains a bone morphogenetic protein, for oral maxillofacial bone grafting procedures. Background information, including the…

PDF format only. Topics: Stents

PDF format only. Topics: LASIK




About

Archive for Food and Drug Adminstration (FDA): CDRHNew.

Food and Drug Adminstration (FDA): CDRHNew

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories